Pushing Proteomics

Genomics is slowly but surely moving off center stage, replaced by proteomics. Though proteomics is a young field that hasn't fully found its stride, two new developments provide glimpses of the future. At the end of February, attendees of the Cambridge Healthtech Institute (CHI) Genome Tri-Conference 2002 in Santa Clara, Calif., got their first glimpse of the Protein Atlas of the Human Genome™. Developed by Abingdon, UK-based Confirmant Ltd.—a joint venture of Abingdon, UK-based Ox

Jim Kling
Apr 14, 2002
Genomics is slowly but surely moving off center stage, replaced by proteomics. Though proteomics is a young field that hasn't fully found its stride, two new developments provide glimpses of the future.

At the end of February, attendees of the Cambridge Healthtech Institute (CHI) Genome Tri-Conference 2002 in Santa Clara, Calif., got their first glimpse of the Protein Atlas of the Human Genome™. Developed by Abingdon, UK-based Confirmant Ltd.—a joint venture of Abingdon, UK-based Oxford GlycoSciences Ltd. and Marconi plc of London—the protein atlas is slated for full release in June.

Explaining the purpose of the atlas, Jonathan Sheldon, Confirmant's chief technology officer and head of bioinformatics, compares it to existing protein databases. "If you look at the protein databases that are out there, they are largely hypothetical," he says. "Analysis at the genetic level also doesn't tell you much about alternative splicing or post-translational modification, or where...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?